HIV-2感染患者对含整合酶抑制剂的高效抗逆转录病毒治疗方案的病毒学和免疫学反应。 - Suppr

Virological and immunological response to HAART regimen containing integrase inhibitors in HIV-2-infected patients.

作者信息

Damond Florence, Lariven Sylvie, Roquebert Benedicte, Males Sylvia, Peytavin Gilles, Morau Genevieve, Toledano Daniel, Descamps Diane, Brun-Vezinet Francoise, Matheron Sophie

出版信息

AIDS. 2008 Mar 12;22(5):665-6. doi: 10.1097/QAD.0b013e3282f51203.

DOI:10.1097/QAD.0b013e3282f51203

PMID:18317013

Abstract

摘要

相似文献

Virological and immunological response to HAART regimen containing integrase inhibitors in HIV-2-infected patients.HIV-2感染患者对含整合酶抑制剂的高效抗逆转录病毒治疗方案的病毒学和免疫学反应。

AIDS. 2008 Mar 12;22(5):665-6. doi: 10.1097/QAD.0b013e3282f51203.

Immunovirological and therapeutic follow-up of HIV-1/HIV-2-dually seropositive patients.HIV-1/HIV-2双重血清阳性患者的免疫病毒学及治疗随访

AIDS. 2009 Jan 28;23(3):426-8. doi: 10.1097/QAD.0b013e328321305a.

Patients presenting with AIDS in the HAART era: a collaborative cohort analysis.高效抗逆转录病毒治疗（HAART）时代的艾滋病患者：一项协作队列分析。

AIDS. 2008 Nov 30;22(18):2461-9. doi: 10.1097/QAD.0b013e328314b5f1.

Raltegravir: new Drug. Alternative to enfuvirtide/darunavir in multidrug-resistant HIV.拉替拉韦：新药。用于多重耐药HIV的恩夫韦肽/达芦那韦替代药物。

Prescrire Int. 2008 Aug;17(96):135-7.

[Advance and perspective of antiretroviral therapy].

Nihon Rinsho. 2010 Mar;68(3):389-94.

Determinants of virological failure after successful viral load suppression in first-line highly active antiretroviral therapy.一线高效抗逆转录病毒治疗中病毒载量成功抑制后病毒学失败的决定因素。

Antivir Ther. 2008;13(7):927-36.

Residual viraemia in HIV-1-infected patients with plasma viral load <or=20 copies/ml is associated with increased blood levels of soluble immune activation markers.血浆病毒载量≤20拷贝/毫升的HIV-1感染患者的残余病毒血症与可溶性免疫激活标志物的血液水平升高有关。

Scand J Immunol. 2008 Dec;68(6):652-60. doi: 10.1111/j.1365-3083.2008.02184.x.

Impact of depression on HIV outcomes in the HAART era.在高效抗逆转录病毒治疗（HAART）时代，抑郁症对艾滋病病毒感染结局的影响。

J Antimicrob Chemother. 2008 Aug;62(2):246-55. doi: 10.1093/jac/dkn193. Epub 2008 May 2.

Preoperative use of raltegravir-containing regimen as induction therapy: very rapid decline of HIV-1 viral load.术前使用含雷特格韦的方案作为诱导疗法：HIV-1病毒载量迅速下降。

AIDS. 2009 Mar 27;23(6):739. doi: 10.1097/QAD.0b013e328325a4bd.

Differential impact of adherence on long-term treatment response among naive HIV-infected individuals.初治HIV感染者中依从性对长期治疗反应的差异影响。

AIDS. 2008 Nov 12;22(17):2371-80. doi: 10.1097/QAD.0b013e328315cdd3.

引用本文的文献

Clinical Outcomes of Integrase Strand Transfer Inhibitors Containing Antiretroviral Therapy in HIV-2: A Narrative Review.HIV-2中含整合酶链转移抑制剂的抗逆转录病毒疗法的临床结局：一项叙述性综述

Infect Dis Ther. 2024 Jun;13(6):1161-1175. doi: 10.1007/s40121-024-00982-7. Epub 2024 May 9.

Antiretroviral Treatment of HIV-2 Infection: Available Drugs, Resistance Pathways, and Promising New Compounds.抗逆转录病毒治疗 HIV-2 感染：现有药物、耐药途径和有前途的新化合物。

Int J Mol Sci. 2023 Mar 21;24(6):5905. doi: 10.3390/ijms24065905.

Comparison of the Antiviral Activity of Bictegravir against HIV-1 and HIV-2 Isolates and Integrase Inhibitor-Resistant HIV-2 Mutants.比较比替拉韦对 HIV-1 和 HIV-2 分离株以及整合酶抑制剂耐药的 HIV-2 突变体的抗病毒活性。

Antimicrob Agents Chemother. 2019 Apr 25;63(5). doi: 10.1128/AAC.00014-19. Print 2019 May.

Antiviral Activity of Cabotegravir against HIV-2.卡博特韦对 HIV-2 的抗病毒活性。

Antimicrob Agents Chemother. 2018 Sep 24;62(10). doi: 10.1128/AAC.01299-18. Print 2018 Oct.

A Trial of a Single-tablet Regimen of Elvitegravir, Cobicistat, Emtricitabine, and Tenofovir Disoproxil Fumarate for the Initial Treatment of Human Immunodeficiency Virus Type 2 Infection in a Resource-limited Setting: 48-Week Results From Senegal, West Africa.在资源有限的环境下，用艾维雷韦、考比司他、恩曲他滨和替诺福韦富马酸酯单片复方制剂治疗人类免疫缺陷病毒 2 型感染的初治方案的试验：来自塞内加尔，西非的 48 周结果。

Clin Infect Dis. 2018 Oct 30;67(10):1588-1594. doi: 10.1093/cid/ciy324.

First-line Raltegravir/Emtricitabine/Tenofovir Combination in Human Immunodeficiency Virus Type 2 (HIV-2) Infection: A Phase 2, Noncomparative Trial (ANRS 159 HIV-2).一线拉替拉韦/恩曲他滨/替诺福韦复方制剂治疗人类免疫缺陷病毒 2 型（HIV-2）感染：一项 2 期、非对照试验（ANRS 159 HIV-2）。

Clin Infect Dis. 2018 Sep 28;67(8):1161-1167. doi: 10.1093/cid/ciy245.

In vitro activity of dolutegravir against wild-type and integrase inhibitor-resistant HIV-2.多替拉韦对野生型和整合酶抑制剂耐药HIV-2的体外活性。

Retrovirology. 2015 Feb 5;12:10. doi: 10.1186/s12977-015-0146-8.

HIV-2 integrase polymorphisms and longitudinal genotypic analysis of HIV-2 infected patients failing a raltegravir-containing regimen.HIV-2整合酶多态性及对含raltegravir方案治疗失败的HIV-2感染患者的纵向基因分型分析

PLoS One. 2014 Mar 28;9(3):e92747. doi: 10.1371/journal.pone.0092747. eCollection 2014.

Characteristics of HIV-2 and HIV-1/HIV-2 Dually Seropositive Adults in West Africa Presenting for Care and Antiretroviral Therapy: The IeDEA-West Africa HIV-2 Cohort Study.西非寻求治疗和抗逆转录病毒疗法的HIV-2以及HIV-1/HIV-2双重血清阳性成年人的特征：IeDEA-西非HIV-2队列研究

PLoS One. 2013 Jun 18;8(6):e66135. doi: 10.1371/journal.pone.0066135. Print 2013.

HIV-1 antiretroviral drug therapy.HIV-1 抗逆转录病毒药物治疗。

Cold Spring Harb Perspect Med. 2012 Apr;2(4):a007161. doi: 10.1101/cshperspect.a007161.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Virological and immunological response to HAART regimen containing integrase inhibitors in HIV-2-infected patients.

作者信息

出版信息

相似文献

引用本文的文献

文献检索

文件翻译

深度研究

Suppr 超能文献

相似文献

引用本文的文献